Cerence financials
$7.83+2.09%
Close Sep 30, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Sep 30 | FY24 Sep 30 | FY23 Sep 30 | FY22 Sep 30 | FY21 Sep 30 | FY20 Sep 30 |
|---|---|---|---|---|---|---|
| Revenue | $251.8M | $331.5M | $294.5M | $327.9M | $387.2M | $331.0M |
| Gross profit | $183.1M | $244.3M | $199.3M | $230.7M | $286.1M | $223.1M |
| Gross margin | 72.7% | 73.7% | 67.7% | 70.4% | 73.9% | 67.4% |
| Operating income | -$2.3M | -$579.9M | -$27.2M | -$184.3M | $60.6M | $22.4M |
| Net income | -$18.7M | -$588.1M | -$56.3M | -$310.8M | $45.9M | -$18.3M |
| Net margin | −7.4% | −177.4% | −19.1% | −94.8% | 11.9% | −5.5% |
| Diluted EPS | $-0.43 | $-14.12 | $-1.40 | $-7.93 | $1.17 | $-0.50 |
| EBITDA | $23.7M | $56.9M | $756.0K | $62.3M | $95.3M | $68.9M |
| Operating cash flow | $61.2M | $17.2M | $7.5M | -$2.1M | $74.4M | $44.8M |
| Free cash flow | $46.8M | $12.2M | $2.4M | -$19.6M | $62.3M | $25.8M |
| Diluted shares | 43.2M | 41.6M | 40.2M | 39.2M | 39.3M | 36.4M |
Balance sheet
| Period end | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $84.0M | $121.5M | $101.2M | $94.8M | $128.4M | $136.1M |
| Short-term investments | $3.4M | $5.5M | $9.2M | $20.3M | $30.4M | $11.7M |
| Total debt | $199.7M | $281.9M | $276.0M | $270.4M | $271.3M | $273.1M |
| Total assets | $630.6M | $702.4M | $1.30B | $1.32B | $1.71B | $1.69B |
| Total liabilities | $479.9M | $561.3M | $602.7M | $605.5M | $673.8M | $727.5M |
| Shareholders' equity | $150.7M | $141.1M | $694.9M | $713.0M | $1.03B | $960.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology